These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1069 related articles for article (PubMed ID: 30688979)

  • 1. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
    ; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
    JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
    Jaeger BC; Bress AP; Bundy JD; Cheung AK; Cushman WC; Drawz PE; Johnson KC; Lewis CE; Oparil S; Rocco MV; Rapp SR; Supiano MA; Whelton PK; Williamson JD; Wright JT; Reboussin DM; Pajewski NM
    JAMA Cardiol; 2022 Nov; 7(11):1138-1146. PubMed ID: 36223105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.
    Nasrallah IM; Gaussoin SA; Pomponio R; Dolui S; Erus G; Wright CB; Launer LJ; Detre JA; Wolk DA; Davatzikos C; Williamson JD; Pajewski NM; Bryan RN;
    JAMA Neurol; 2021 May; 78(5):568-577. PubMed ID: 33683313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.
    Marcum ZA; Cohen JB; Zhang C; Derington CG; Greene TH; Ghazi L; Herrick JS; King JB; Cheung AK; Bryan N; Supiano MA; Sonnen JA; Weintraub WS; Williamson J; Pajewski NM; Bress AP;
    JAMA Netw Open; 2022 Jan; 5(1):e2145319. PubMed ID: 35089354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.
    ; Nasrallah IM; Pajewski NM; Auchus AP; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Doshi J; Erus G; Fine LJ; Gaussoin SA; Harris D; Johnson KC; Kimmel PL; Kurella Tamura M; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB; Williamson JD; Bryan RN
    JAMA; 2019 Aug; 322(6):524-534. PubMed ID: 31408137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD
    J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
    JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.
    Hughes D; Judge C; Murphy R; Loughlin E; Costello M; Whiteley W; Bosch J; O'Donnell MJ; Canavan M
    JAMA; 2020 May; 323(19):1934-1944. PubMed ID: 32427305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24-Hour Blood Pressure Variability Via Ambulatory Monitoring and Risk for Probable Dementia in the SPRINT Trial.
    Sible IJ; Nation DA
    J Prev Alzheimers Dis; 2024; 11(3):684-692. PubMed ID: 38706284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.
    Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM;
    JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
    ; Lewis CE; Fine LJ; Beddhu S; Cheung AK; Cushman WC; Cutler JA; Evans GW; Johnson KC; Kitzman DW; Oparil S; Rahman M; Reboussin DM; Rocco MV; Sink KM; Snyder JK; Whelton PK; Williamson JD; Wright JT; Ambrosius WT
    N Engl J Med; 2021 May; 384(20):1921-1930. PubMed ID: 34010531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial.
    Jiang C; Lai Y; Du X; Wang Y; Li S; He L; Hu R; Lv Q; Wu J; Feng L; Ning M; Ruan Y; Li X; Jia C; Dai W; Guo X; Jiang C; Tang R; Sang C; Long D; Arima H; Dong J; Anderson CS; Ma C
    Europace; 2022 Oct; 24(10):1560-1568. PubMed ID: 35640916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
    Kurella Tamura M; Gaussoin SA; Pajewski NM; Chelune GJ; Freedman BI; Gure TR; Haley WE; Killeen AA; Oparil S; Rapp SR; Rifkin DE; Supiano M; Williamson JD; Weiner DE;
    J Am Soc Nephrol; 2020 Sep; 31(9):2122-2132. PubMed ID: 32591439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial.
    Li S; Jiang C; Wang Y; Lai Y; Zhao M; Li Q; Bai Y; Dai W; Guo Q; He L; Guo X; Wang W; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
    Hypertension; 2023 Aug; 80(8):1628-1636. PubMed ID: 37165869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
    Peters R; Beckett N; Forette F; Tuomilehto J; Clarke R; Ritchie C; Waldman A; Walton I; Poulter R; Ma S; Comsa M; Burch L; Fletcher A; Bulpitt C;
    Lancet Neurol; 2008 Aug; 7(8):683-9. PubMed ID: 18614402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.